Roy Jones Selected Research

Mixed Dementias

1/2017	Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
5/2013	Goal-oriented cognitive rehabilitation in early-stage dementia: study protocol for a multi-centre single-blind randomised controlled trial (GREAT).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roy Jones Research Topics

Disease

13	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 12/2002
9	Dementia (Dementias) 01/2017 - 11/2006
4	Infections 02/2017 - 04/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2017 - 08/2006
3	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2015 - 08/2004
3	Hematologic Neoplasms (Hematological Malignancy) 05/2015 - 07/2010
3	Multiple Myeloma 10/2013 - 09/2008
2	Heart Failure 01/2018 - 01/2016
2	Hemorrhagic Cystitis 02/2017 - 07/2010
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2017 - 11/2006
2	Cognitive Dysfunction 01/2017 - 11/2006
2	Frontotemporal Dementia (Semantic Dementia) 01/2017 - 01/2008
2	Mixed Dementias 01/2017 - 05/2013
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 10/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017 - 04/2005
2	Lymphoma (Lymphomas) 01/2017 - 04/2005
2	Herpes Zoster 03/2010 - 06/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2008 - 08/2004
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Hemorrhage 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Pathologic Constriction (Stenosis) 02/2017
1	Residual Neoplasm 02/2017
1	Neurobehavioral Manifestations 01/2017
1	Pancytopenia 05/2016
1	Pure Red-Cell Aplasia 05/2016
1	Neoplasms (Cancer) 02/2014
1	Disease Progression 10/2013
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 06/2012
1	Philadelphia Chromosome 04/2012
1	Stroke (Strokes) 10/2010
1	Myeloid Leukemia (Leukemia, Myelocytic) 11/2008
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2008
1	Wernicke Aphasia (Receptive Aphasia) 01/2008
1	Lewy Body Disease (Lewy Body Dementia) 11/2006
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2006
1	Blast Crisis (Blast Phase) 08/2006
1	Breast Neoplasms (Breast Cancer) 11/2004
1	Rupture 11/2004

Drug/Important Bio-Agent (IBA)

7	Donepezil (Aricept)FDA LinkGeneric 01/2017 - 11/2006
6	Memantine (Namenda)FDA Link 01/2017 - 11/2006
5	Busulfan (Busulfex)FDA Link 01/2020 - 08/2004
4	fludarabineIBA 01/2020 - 08/2004
4	Pharmaceutical PreparationsIBA 12/2015 - 11/2006
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2017 - 11/2006
3	Melphalan (Alkeran)FDA LinkGeneric 01/2017 - 04/2005
3	Carmustine (FIVB)FDA Link 01/2017 - 11/2004
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2017 - 11/2006
2	Rituximab (Mabthera)FDA Link 01/2017 - 04/2005
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2017 - 04/2005
2	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 04/2005
2	Galantamine (Galanthamine)FDA LinkGeneric 01/2017 - 11/2006
2	Vitamin E FDA LinkGeneric 01/2017 - 11/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015 - 11/2004
2	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 08/2004
1	eltrombopag FDA Link 01/2021
1	Clofarabine (Clolar)FDA Link 02/2017
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2016
1	Hemagglutinins (Hemagglutinin)IBA 05/2016
1	Calcineurin InhibitorsIBA 05/2015
1	FM 100 (FM100)IBA 10/2013
1	SteroidsIBA 06/2012
1	Intravenous Immunoglobulins (IVIG)FDA Link 06/2012
1	Tyrosine Kinase InhibitorsIBA 04/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2010
1	CholesterolIBA 03/2010
1	GangliosidesIBA 03/2010
1	methyl-beta-cyclodextrinIBA 03/2010
1	LipidsIBA 03/2010
1	Octoxynol (Triton X 100)IBA 03/2010
1	Lenalidomide (CC 5013)FDA Link 06/2009
1	Filgrastim (Neupogen)FDA Link 06/2009
1	theasinensin AIBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 06/2007
1	Glycoproteins (Glycoprotein)IBA 06/2007
1	proacrosinIBA 06/2007
1	MetalsIBA 11/2006
1	Phosphotransferases (Kinase)IBA 08/2006
1	Imatinib Mesylate (Gleevec)FDA Link 08/2006
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2004

Therapy/Procedure

10	Hematopoietic Stem Cell Transplantation 01/2021 - 08/2004
6	Therapeutics 01/2017 - 11/2004
4	Transplantation 01/2021 - 02/2014
4	Drug Therapy (Chemotherapy) 01/2017 - 11/2004
4	Stem Cell Transplantation 01/2017 - 04/2005
2	Patient Readmission 01/2018 - 01/2016
2	Activities of Daily Living (ADL) 07/2012 - 01/2011
1	Length of Stay 02/2017
1	Home Nursing (Nursing, Home) 12/2015
1	Cognitive Training 05/2013
1	Plasmapheresis 06/2012
1	Institutionalization (Institutionalized Persons) 07/2009
1	Hematopoietic Stem Cell Mobilization 06/2009
1	Phototherapy (Light Therapy) 11/2006
1	Aromatherapy 11/2006
1	Ligation 11/2004